Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume – What’s Next?

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw unusually-strong trading volume on Monday . 22,371 shares traded hands during trading, a decline of 17% from the previous session’s volume of 26,951 shares.The stock last traded at $9.48 and had previously closed at $9.2850.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy”.

Nihon Kohden Stock Performance

The firm has a fifty day moving average price of $8.97 and a two-hundred day moving average price of $9.96. The stock has a market capitalization of $1.59 billion, a P/E ratio of 16.09 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The company had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. On average, research analysts anticipate that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.